MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD9 Codes        Equipment        Hospitals        Drugs        More..
  

Useful Websites

Global Translations
Medical and Clinical Translation

specialistinfo.com
Details of over 40,000 UK Specialists and over 42,000 GPs

Global RPH
medical software

Doctors Lounge
Ask a Doctor and Disease Information

Health News
from Medical News Today.

MRCP 1 Revision
123 Doc medical courses for junior doctors.

CoreyNahman
pharmaceutical news daily

Hospital Search
Worldwide hospital database, search by country or keyword.

Metric Conversions
The Converter Site - unit conversion tool.
headlines news headlines   email email to a friend   printer printer friendly   newsletter sign up to newsletter  

Discovery Allows Scientists For The First Time To Experimentally Annotate Genomes

Main Category: Genetics
Also Included In: Infectious Diseases / Bacteria / Viruses | IT / Internet / E-mail
Article Date: 11 Nov 2009

Over the last 20 years, the sequencing of the human genome, along with related organisms, has represented one of the largest scientific endeavors in the history of mankind. The information collected from genome sequencing will provide the raw data for the field of bioinformatics, where computer science and biology meet. Since the publication of the first full genome sequence in the mid-1990s, scientists have been working to identify the genomic location of all the gene products involved in the complex biological processes in a single organism. However, they have only been able to identify a fraction of those locations. Until now. Bioengineers at UC San Diego have made a breakthrough development that will now allow scientists to perform full delineation of the location and use of genomic elements. The researchers have discovered that multiple simultaneous genome-scale measurements are needed to identify all gene products, and to determine their cellular locations and interactions with the genome.

In a recent Nature Biotechnology paper, "The transcription unit architecture of the Escherichia coli genome," the researchers describe a four-step systems approach that integrates multiple genome-scale measurements on the basis of genetic information flow to identify the organizational elements and map them onto the genome sequence. The bioengineers have applied this approach to the E. coli genome to generate a detailed description of its transcription unit architecture.

"What's important about this paper is it now enables us to experimentally annotate genomes," said Bernard Palsson, a UCSD bioengineering professor and co-author of the paper. "All this information gives us a fine resolution of the contents of a genome and location of its elements. This is a fine blueprint of a genetic makeup of the genome. We have been able to use genome scale computational models that have been developed at UCSD under the systems biology program, which have enabled us to compute organism designs with higher resolution or better accuracy, which has not been possible before. It takes a lot of the guesswork out of making an organism. Currently there is extensive trial and error in gene sequencing procedures. Hopefully this 'metastucture' of a genome that we have developed will eliminate that trial and error and will enable us to reach new metabolic designs faster with lower failure rates."

Palsson said there are many significant implications of this new finding, such as enhancing metabolic engineering (such as the engineering of microorganisms to make fuels and commodity chemicals).

The UCSD bionengineers combined several computation methods with information mapping in this research. "There are several high throughput methods developed recently like deep sequencing and micro array systems that we used," said Byung-Kwan Cho, a project scientist in the UCSD bioengineering department and the lead author of the Nature Biotechnology paper. "We wanted to integrate all the information into one format to describe the genome. We have genome sequences but we don't know what all of them are. When we sequenced the Human Genome we thought we knew everything but actually we don't know everything. There are lots of data generation techniques and a huge amount of data available. So we were able to map all of this information into one genome sequence.

"So far, scientists have been able to make chemicals to kill pathogenic strains but we haven't been as successful as we have wanted to be," Cho added. "By using this newly discovered information we may be able to design better drugs or medicines to kill pathogenic strains. That's the important point of this research - there is a huge amount of applications for this. The E. coli bacteria is just the beginning."

Source: Andrea Siedsma
University of California - San Diego

Original article posted on Medical News Today.
Articles not to be reproduced without permission of Medical News Today

Medical News Today publishes the latest health news and health videos for consumers and health professionals. It has a searchable archive of over 100,000 health news articles.





For any corrections of factual information, or to contact the editors please use our feedback form.
Send your press releases to








free web search box


pda medical dictionary
pda software - $15

PDA Medical Dictionary

only $15

Take MediLexicon's abbreviations search with you where-ever you go with our PDA software. As an extra, this software is available with an extra medical dictionary...

>> Click here for more on the PDA Medical Dictionary <<




add to google

Add our searches to your Google homepage.

Add to Google

The 60 seconds challenge: Add these searches to your Google homepage within 60 seconds - simply click here and follow these instructions


Receive the latest medical news on your Google homepage.

Add to Google

The 60 seconds challenge: Receive the latest medical news on your Google homepage within 60 seconds - simply click here and follow these instructions





Privacy Policy   |    Disclaimer      

MediLexicon International Ltd, UK Office: +44 (0) 1625 415 347
MediLexicon International Ltd © 2009 All rights reserved.